Glenmede Trust’s AdaptHealth AHCO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$328K Buy
27,544
+291
+1% +$2.98K ﹤0.01% 1122
2025
Q4
$271K Buy
+27,253
New +$260K ﹤0.01% 1180
2025
Q1
$305K Buy
28,096
+4,086
+17% +$41.1K ﹤0.01% 1078
2024
Q4
$229K Buy
24,010
+7,557
+46% +$76.5K ﹤0.01% 1196
2024
Q3
$185K Buy
16,453
+4,556
+38% +$48.4K ﹤0.01% 1245
2024
Q2
$119K Buy
+11,897
New +$121K ﹤0.01% 1240

Other funds holding AHCO

Glenmede Trust's AHCO Position: Q1 2026 in Review

Glenmede Trust increased its AdaptHealth (AHCO) stake by 1.1% in Q1 2026, buying an estimated $2.98K and bringing the position to 27,544 shares worth $328K. The position accounts for ﹤0.01% of the portfolio, ranked #1122.

Glenmede Trust first reported a position in AHCO in Q2 2024 and has held it in 6 quarters since. 241 funds tracked by Wall St. Rank hold AHCO as of Q1 2026.

  • Glenmede Trust held 27,544 shares of AdaptHealth worth $328K as of Q1 2026.
  • Glenmede Trust bought 291 AdaptHealth shares in Q1 2026, an estimated $2.98K.
  • AdaptHealth made up ﹤0.01% of Glenmede Trust's portfolio in Q1 2026, its #1122 holding.
  • Glenmede Trust first reported a position in AdaptHealth in Q2 2024 and has held it in 6 quarters since.
  • 241 funds tracked by Wall St. Rank held AdaptHealth as of Q1 2026.

Based on Glenmede Trust's 13F filing for Q1 2026, filed 26 May 2026.